Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EQ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EQ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EQ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EQ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JU.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JU.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JU.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JU.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JU.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CJ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CJ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CJ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
B.1.160.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-4838.81South Korea
B.1.160.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
B.1.160.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.160.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.160.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.160.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.4.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.4.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.4.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used